Christopher Locher

Christopher Locher

Company: Versatope Therapeutics Inc.

Job title: Chief Executive Officer


Workshop Leaders: 1:00 pm

This workshop will cover: Reviewing the properties and scalability potential of new cell lines that are yet to receive regulatory approval Assessing the potential and possible safety risks of using an SF9 baculovirus cell line expression system Elucidating on the possibility of Baby Hamster Kidney (BHK) cell lines to carry the risk of evolving undesirable…Read more

day: Pre-Conference Workshop Day

Fireside Chat: Discussing the Hurdles in Developing a Fully Scalable Cell Line 9:15 am

Exploring approaches towards increasing the scalability of established cell lines Tackling density thresholds, cell media and productivity decreases Regaining control of cell lines, reducing genetic drift, and increasing stabilityRead more

day: Conference Day 1

Optimizing Cell Line Expression Using Microbial Factories for Better Scale Up 9:30 am

Encapsulating an alternative, virus free approach to mammalian protein expression Using bioinformatics to inform the development process Addressing issues in scale up by using the microbial factory approachRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.